TENAX THERAPEUTICS, INC. (TENX) Operating cash flow 2016–2025
TENAX THERAPEUTICS, INC. (TENX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$35.8MFY2025 · since FY2016: -$15.9M → -$35.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.8M | -141.7% |
| FY2024 | -$14.8M | -150.9% |
| FY2023 | -$5.9M | +48.2% |
| FY2022 | -$11.4M | -4.9% |
| FY2021 | -$10.9M | -17.1% |
| FY2020 | -$9.3M | -22.7% |
| FY2019 | -$7.6M | -37.4% |
| FY2018 | -$5.5M | +54.7% |
| FY2017 | -$12.1M | +23.5% |
| FY2016 | -$15.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice